Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-11 · 1872 (8) · 168346
DOI: 10.1016/j.bbadis.2026.168346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-11. Verfasst von Zhuangwei Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Forensic Medicine, Xinxiang Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Carcinoma, Hepatocellular, Liver Neoplasms, Tumor Microenvironment. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Henan Province Natural Science Foundation.
Abstract (Originalsprache)
Activation-induced cytidine deaminase (AID) is known to contribute to cancer progression, yet its role in immune evasion and tumor microenvironment (TME) associated features in hepatocellular carcinoma (HCC) remains unclear. In this study, we show that AID is associated with immune cell infiltration in the TME of HCC and contributes to the activation of the oncostatin M receptor (OSMR)-STAT3 signaling axis. High AID expression correlated with poor prognosis in HCC patients, while genetic ablation of AID inhibited tumor proliferation and enhanced the infiltration of cytotoxic T cells into the TME. Mechanistically, loss of OSMR abolished the oncogenic effects of AID, indicating that OSMR-dependent signaling is required for AID-driven HCC aggressiveness. Moreover, STAT3 deletion attenuated the pro-tumor functions of AID, affirming the pivotal role of STAT3 signaling. Combined inhibition of the AID-OSMR-STAT3 axis significantly suppressed HCC growth and altered the immune landscape in association with increased infiltration of CD4+ T cells, CD8+ T cells, and B cells. These results identify AID as a regulator of immune evasion in HCC via OSMR-STAT3 activation and suggest that coordinated targeting of this pathway could offer a therapeutic strategy to modulate immunosuppression and enhance anti-tumor immunity, with potential implications for improving current immunotherapies in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Forensic Medicine, Xinxiang Medical University, Xinxiang, China.
- School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxian…
- School of Junji College, Xinxiang Medical University, Xinxiang, Henan, 453003, China.
- School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Förderung
- Henan Province Natural Science Foundation
Zitieren
APA
Lv, Z., Jiao, J., Shi, X., Nie, Z., Wang, R., Wu, J., Wang, C., & Huang, Y. (2026). Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(8), 168346. https://doi.org/10.1016/j.bbadis.2026.168346
Vancouver
Lv Z, Jiao J, Shi X, Nie Z, Wang R, Wu J, et al. Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(8):168346. doi:10.1016/j.bbadis.2026.168346
BibTeX
@article{Lv2026,
author = {Lv, Zhuangwei and Jiao, Junna and Shi, Xiaoyu and Nie, Ziru and Wang, Ruihan and Wu, Jinhua and Wang, Cuiling and Huang, Yanmei},
title = {Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2026},
volume = {1872},
number = {8},
pages = {168346},
doi = {10.1016/j.bbadis.2026.168346}
}
EUVIMED